We are live on
!
Find out more
Wealthfront Advisers Portfolio holdings
AUM
$52B
Turnover
7.12%
1-Year Est. Return
24.53%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+24.53%
3 Year Est. Return
+63.26%
5 Year Est. Return
+56.07%
10 Year Est. Return
–
AUM
$52B
AUM Growth
+$6.48B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
2.26%
Top 10 Holdings %
Top 10 Hldgs %
56.09%
Holding
1,138
New
62
Increased
608
Reduced
447
Closed
19
Avg Time Held
4.2
years
Top 10 Avg Time Held
5.5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$185M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$117M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$109M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$97.4M |
| 5 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$64.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$70M |
| 2 |
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
+$39M |
| 3 |
Schwab US Broad Market ETF
SCHB
|
+$31.4M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$20.6M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 80.91% |
| 2 | Technology | 7.11% |
| 3 | Financials | 2.31% |
| 4 | Communication Services | 1.83% |
| 5 | Industrials | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
GoodRx Holdings
GDRX
$1.17B
| $81.6K | ﹤0.01% |
28,342
+212
| +0.8% | +$539 |
2026 Q1
1 quarter
|
|
1102
Cabaletta Bio
CABA
$259M
| $75.8K | ﹤0.01% |
+24,389
| New | +$80.2K |
2026 Q2
0 quarters
|
|
1103
Alight
ALIT
$241M
| $70.9K | ﹤0.01% |
6,333
| – | – |
2025 Q3
3 quarters
|
|
1104
New Fortress Energy
NFE
$24.3M
| $70.8K | ﹤0.01% |
3,901
-18
| -0.5% | -$535 |
2025 Q4
2 quarters
|
|
1105
Pacific Biosciences
PACB
$606M
| $66.4K | ﹤0.01% |
39,511
+65
| +0.2% | +$95 |
2024 Q2
8 quarters
|
|
1106
Chegg
CHGG
$85.2M
| $63.2K | ﹤0.01% |
62,585
-964
| -2% | -$1.06K |
2025 Q1
5 quarters
|
|
1107
Virgin Galactic
SPCE
$385M
| $57K | ﹤0.01% |
+19,712
| New | +$64.4K |
2026 Q2
0 quarters
|
|
1108
Sable Offshore Corp
SOC
$643M
| $56.6K | ﹤0.01% |
18,384
+861
| +5% | +$11K |
2025 Q4
2 quarters
|
|
1109
Recursion Pharmaceuticals
RXRX
$2.25B
| $54.4K | ﹤0.01% |
14,820
+2,610
| +21% | +$8.69K |
2025 Q3
3 quarters
|
|
1110
Iovance Biotherapeutics
IOVA
$6.48B
| $53.9K | ﹤0.01% |
+12,959
| New | +$49.2K |
2026 Q2
0 quarters
|
|
1111
American Battery Technology Co
ABAT
$220M
| $52K | ﹤0.01% |
18,384
+1,047
| +6% | +$3.35K |
2026 Q1
1 quarter
|
|
1112
indie Semiconductor
INDI
$459M
| $48K | ﹤0.01% |
+10,695
| New | +$42.7K |
2026 Q2
0 quarters
|
|
1113
Aquestive Therapeutics
AQST
$520M
| $44.4K | ﹤0.01% |
10,679
-1,448
| -12% | -$6.09K |
2026 Q1
1 quarter
|
|
1114
Prime Medicine
PRME
$628M
| $41.7K | ﹤0.01% |
11,301
+922
| +9% | +$3.06K |
2026 Q1
1 quarter
|
|
1115
JELD-WEN Holding
JELD
$121M
| $34.2K | ﹤0.01% |
22,785
| – | – |
2025 Q4
2 quarters
|
|
1116
Hertz
HTZ
$692M
| $26.8K | ﹤0.01% |
+11,835
| New | +$64.6K |
2026 Q2
0 quarters
|
|
1117
Blink Charging
BLNK
$63M
| $21.9K | ﹤0.01% |
34,166
-107
| -0.3% | -$77 |
2023 Q4
10 quarters
|
|
1118
GoPro
GPRO
$235M
| $10.5K | ﹤0.01% |
13,494
-51
| -0.4% | -$54 |
2024 Q1
9 quarters
|
|
1119
Xerox Holdings Corp Warrants
XRXDW
$16M
| $3.35K | ﹤0.01% |
12,194
-426
| -3% | -$116 |
2026 Q1
1 quarter
|
|
1120
Chemours
CC
$1.92B
| – | – |
-42,567
| Closed | -$938K | – |
|
1121
Chewy
CHWY
$8.57B
| – | – |
-8,050
| Closed | -$217K | – |
|
1122
Clover Health Investments
CLOV
$2.46B
| – | – |
-13,023
| Closed | -$22.9K | – |
|
1123
DELISTED
Coterra Energy
CTRA
| – | – |
-165,091
| Closed | -$5.8M | – |
|
1124
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$14.9B
| – | – |
-2,833
| Closed | -$202K | – |
|
1125
DELISTED
Hologic
HOLX
| – | – |
-61,471
| Closed | -$4.65M | – |
|
Similar funds
Wealthfront Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Wealthfront Advisers held 1,138 positions worth $52B, up 14% from $45.6B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Wealthfront Advisers's Q2 2026 filing shows 62 new, 608 increased, 447 reduced and 19 closed positions. Its largest new stake was Honeywell Aerospace: 54,444 shares worth $12M. The largest sale was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $70M.
By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, down from 82% a quarter earlier, followed by Technology and Financials.
- Wealthfront Advisers's largest Q2 2026 buy was Honeywell Aerospace: 54,444 shares worth $12M.
- Wealthfront Advisers added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2026, an estimated $185M increase.
- Wealthfront Advisers's biggest Q2 2026 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $70M.
- Wealthfront Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $5.8M.
- Wealthfront Advisers's ten largest holdings make up 56% of its $52B portfolio in Q2 2026.
- Wealthfront Advisers opened 62 new positions and closed 19 in Q2 2026.
- Wealthfront Advisers's portfolio value rose 14% quarter-over-quarter to $52B.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.